Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The receptor binding domain of the tetanus neurotoxin (TeNT), produced by *Clostridium tetani*, is a critical region responsible for the high-affinity and specific attachment of the toxin to neuronal cells. This domain is located at the C-terminus of the heavy chain (HC) of TeNT, often referred to as fragment C or HCR/T, and is essential for initiating intoxication by mediating entry into neurons. It binds to gangliosides and potentially protein receptors on the neuronal surface, facilitating endocytosis and retrograde transport of the toxin into the central nervous system.
Not applicable, this is a domain, not a drug target. The mechanism relates to how the toxin itself acts, not how drugs target it.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Clostridium tetani Toxin Receptor Binding Domain (TeNT HCR/T).